Copenfast trial: fetal growth and glycemic control in pregnant women with type 1 or type 2 diabetes randomized to faster‐acting insulin aspart or insulin aspar

Sidse Kjærhus Nørgaard; Julie Carstens Søholm; Elisabeth Mathiesen; Kirsten Nørgaard; Tine Dalsgaard  Clausen; Pernille Holmager; Nicoline Callesen Do; Peter Damm; Lene Ringholm

doi:10.1089/dia.2024.2525.abstracts

Copenfast trial: fetal growth and glycemic control in pregnant women with type 1 or type 2 diabetes randomized to faster‐acting insulin aspart or insulin aspar

Sidse Kjærhus Nørgaard, Julie Carstens Søholm, Elisabeth Mathiesen, Kirsten Nørgaard, Tine Dalsgaard Clausen, Pernille Holmager, Nicoline Callesen Do, Peter Damm, Lene Ringholm

Original language	English
Article number	O054 / #1236
Journal	Diabetes Technology & Therapeutics
Volume	26
Issue number	s2
ISSN	1520-9156
DOIs	https://doi.org/10.1089/dia.2024.2525.abstracts
Publication status	Published - Feb 2024
Event	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes - Florence, Italy Duration: 6 Mar 2024 → 9 Mar 2024 https://attd.kenes.com/

Conference

Conference	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes
Country/Territory	Italy
City	Florence
Period	06/03/2024 → 09/03/2024
Internet address	https://attd.kenes.com/

Access to Document

10.1089/dia.2024.2525.abstracts

Cite this

Nørgaard, S. K., Søholm, J. C., Mathiesen, E., Nørgaard, K., Clausen, T. D., Holmager, P., Do, N. C., Damm, P., & Ringholm, L. (2024). Copenfast trial: fetal growth and glycemic control in pregnant women with type 1 or type 2 diabetes randomized to faster‐acting insulin aspart or insulin aspar. Diabetes Technology & Therapeutics, 26(s2), Article O054 / #1236 . https://doi.org/10.1089/dia.2024.2525.abstracts

Copenfast trial: fetal growth and glycemic control in pregnant women with type 1 or type 2 diabetes randomized to faster‐acting insulin aspart or insulin aspar. / Nørgaard, Sidse Kjærhus; Søholm, Julie Carstens; Mathiesen, Elisabeth et al.
In: Diabetes Technology & Therapeutics, Vol. 26, No. s2, O054 / #1236 , 02.2024.

Research output: Contribution to journal › Conference abstract in journal › Research

Nørgaard, SK, Søholm, JC, Mathiesen, E , Nørgaard, K , Clausen, TD , Holmager, P , Do, NC , Damm, P & Ringholm, L 2024, 'Copenfast trial: fetal growth and glycemic control in pregnant women with type 1 or type 2 diabetes randomized to faster‐acting insulin aspart or insulin aspar', Diabetes Technology & Therapeutics, vol. 26, no. s2, O054 / #1236 . https://doi.org/10.1089/dia.2024.2525.abstracts

@article{1f24e1f2ce754b259e3c4a074981b8e5,

title = "Copenfast trial: fetal growth and glycemic control in pregnant women with type 1 or type 2 diabetes randomized to faster‐acting insulin aspart or insulin aspar",

author = "N{\o}rgaard, \{Sidse Kj{\ae}rhus\} and S{\o}holm, \{Julie Carstens\} and Elisabeth Mathiesen and Kirsten N{\o}rgaard and Clausen, \{Tine Dalsgaard\} and Pernille Holmager and Do, \{Nicoline Callesen\} and Peter Damm and Lene Ringholm",

year = "2024",

month = feb,

doi = "10.1089/dia.2024.2525.abstracts",

language = "English",

volume = "26",

journal = "Diabetes Technology \& Therapeutics",

issn = "1520-9156",

publisher = "SAGE Publications Ltd",

number = "s2",

note = "ATTD 2024 - 17th International Conference on Advanced Technologies \& Treatments for Diabetes, ATTD 2024 ; Conference date: 06-03-2024 Through 09-03-2024",

url = "https://attd.kenes.com/",

}

TY - ABST

T1 - Copenfast trial: fetal growth and glycemic control in pregnant women with type 1 or type 2 diabetes randomized to faster‐acting insulin aspart or insulin aspar

AU - Nørgaard, Sidse Kjærhus

AU - Søholm, Julie Carstens

AU - Mathiesen, Elisabeth

AU - Nørgaard, Kirsten

AU - Clausen, Tine Dalsgaard

AU - Holmager, Pernille

AU - Do, Nicoline Callesen

AU - Damm, Peter

AU - Ringholm, Lene

PY - 2024/2

Y1 - 2024/2

U2 - 10.1089/dia.2024.2525.abstracts

DO - 10.1089/dia.2024.2525.abstracts

M3 - Conference abstract in journal

SN - 1520-9156

VL - 26

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - s2

M1 - O054 / #1236

T2 - ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes

Y2 - 6 March 2024 through 9 March 2024

ER -